Glucophage-SR
Glucophage-SR is the sustained-release formulation of metformin, a first-line medication used in the management of type 2 diabetes mellitus. By improving insulin sensitivity and decreasing hepatic glucose production, Glucophage-SR plays a vital role in controlling blood sugar levels. The sustained-release formulation is designed to release metformin gradually, which can improve gastrointestinal tolerability and enhance patient compliance.
The mechanism of action of metformin involves several pathways. Primarily, it decreases hepatic gluconeogenesis, meaning that the liver produces less glucose. It also increases peripheral glucose uptake, particularly in muscle tissue, thereby improving insulin sensitivity. This dual action helps lower fasting and postprandial blood glucose levels, contributing to better overall glycemic control.
Glucophage-SR is administered orally, usually once or twice daily with meals, which helps minimize gastrointestinal side effects such as nausea, abdominal discomfort, and diarrhea. The sustained-release formulation allows for a more gradual absorption of the medication into the bloodstream, which can lead to a more stable plasma concentration and improved tolerability compared to immediate-release forms.
While Glucophage-SR is generally well tolerated, some patients may still experience mild side effects, predominantly related to the gastrointestinal system. These side effects are often transient and can be minimized by starting with a low dose and gradually increasing to the target dose. Regular monitoring of blood glucose levels and periodic assessment of kidney function are important to ensure the medication remains both effective and safe.
In summary, Glucophage-SR is a valuable treatment option for patients with type 2 diabetes. Its sustained-release formulation offers the benefits of metformin's proven efficacy in reducing blood sugar levels while enhancing gastrointestinal tolerability. With proper dosing, lifestyle modifications, and regular monitoring, Glucophage-SR can help patients achieve improved glycemic control and reduce the long-term complications associated with diabetes.
NOTE: The above information is for marketing purposes only and is not to be construed as medical advice. Seek advice for medications from a qualified physician.
The mechanism of action of metformin involves several pathways. Primarily, it decreases hepatic gluconeogenesis, meaning that the liver produces less glucose. It also increases peripheral glucose uptake, particularly in muscle tissue, thereby improving insulin sensitivity. This dual action helps lower fasting and postprandial blood glucose levels, contributing to better overall glycemic control.
Glucophage-SR is administered orally, usually once or twice daily with meals, which helps minimize gastrointestinal side effects such as nausea, abdominal discomfort, and diarrhea. The sustained-release formulation allows for a more gradual absorption of the medication into the bloodstream, which can lead to a more stable plasma concentration and improved tolerability compared to immediate-release forms.
While Glucophage-SR is generally well tolerated, some patients may still experience mild side effects, predominantly related to the gastrointestinal system. These side effects are often transient and can be minimized by starting with a low dose and gradually increasing to the target dose. Regular monitoring of blood glucose levels and periodic assessment of kidney function are important to ensure the medication remains both effective and safe.
In summary, Glucophage-SR is a valuable treatment option for patients with type 2 diabetes. Its sustained-release formulation offers the benefits of metformin's proven efficacy in reducing blood sugar levels while enhancing gastrointestinal tolerability. With proper dosing, lifestyle modifications, and regular monitoring, Glucophage-SR can help patients achieve improved glycemic control and reduce the long-term complications associated with diabetes.
NOTE: The above information is for marketing purposes only and is not to be construed as medical advice. Seek advice for medications from a qualified physician.
Glucophage SR
Metformin SR
Generic: METSMALL SR
Metformin SR
Generic: METSMALL SR
1000mg
30 TAB
30 TAB
$21.31
Glucophage SR
Metformin SR
Generic: METSMALL SR
Metformin SR
Generic: METSMALL SR
500mg
30 TAB
30 TAB
$3.24